Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines.

NPJ Vaccines · 2022 · PMC9593992 · PMID 36284110

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

However, older ZVL recipients showed a trend toward an increase from pre-vaccination to peak response (43 versus 53 pg/ml; p = 0.08; Wilcoxon matched-pairs signed rank test), while older RZV recipients showed significant increases (65 versus 92 pg/ml; p = 0.03).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.